The US Food and Drug Administration (FDA), in updating the Purple Book, its database of FDA-licensed biologic products, will also include exclusivity information for biological products as well as a ...
The US Food and Drug Administration (FDA) on Wednesday unveiled a new database on the various antiretroviral (ARV) HIV drugs available to purchase through the President’s Emergency Plan for AIDS ...
The FDA has launched a new adverse event reporting system that will consolidate several systems it has for reporting different types of adverse events, the agency announced Wednesday. The new system, ...
BALA CYNWYD, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare ...
The FDA has launched a free mobile app version of its Drugs@FDA online database that offers consumers information on agency-approved drugs. The new app, called Drugs@FDA Express, is free and currently ...
Combinations of cancer drugs have the potential to overcome resistance, improve the response rate of existing drugs and reduce dose-limiting toxicity associated with single agents. Existing drug ...
FDA databases that physicians and public health experts rely on for key drug safety and manufacturing information have been neglected due to DOGE-directed layoffs, leaving health professionals flying ...
What drugs does the Food and Drug Administration (FDA) block patients and doctors from accessing that Canadian patients and doctors can get? To address the question, we compared the contents of the ...
On July 10, 2025, citing a drive to increase transparency, the Food and Drug Administration (“FDA”) published more than 200 complete response letters (CRLs) previously issued to companies that had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results